Stockreport

Popular Weight-Loss Drug Wegovy Unveils Subscription Service [MSNBC.com]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Novo Nordisk is unveiling a subscription model for self-pay customers of its popular GLP-1 weight loss drug Wegovy with much lower prices for both the injectable and the [Read more]